cbdMD (NYSEAMERICAN:YCBD) Shares Down 1.1% – Here’s What Happened

cbdMD, Inc. (NYSEAMERICAN:YCBD)’s share price dropped 1.1% on Friday . The company traded as low as $0.69 and last traded at $0.6951. 227,107 shares changed hands during trading, an increase of 55% from the average session volume of 146,633 shares. The stock had previously closed at $0.7030.

cbdMD Trading Down 1.1%

The company has a fifty day simple moving average of $0.78 and a two-hundred day simple moving average of $0.88.

cbdMD (NYSEAMERICAN:YCBD) last released its earnings results on Thursday, May 14th. The company reported ($0.08) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.03). cbdMD had a negative return on equity of 33.60% and a negative net margin of 13.29%.The firm had revenue of $5.64 million for the quarter, compared to analysts’ expectations of $5.29 million.

Institutional Investors Weigh In On cbdMD

A hedge fund recently bought a new stake in cbdMD stock. Jane Street Group LLC acquired a new position in shares of cbdMD, Inc. (NYSEAMERICAN:YCBD) in the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 51,141 shares of the company’s stock, valued at approximately $69,000. Jane Street Group LLC owned about 0.49% of cbdMD at the end of the most recent quarter. 7.18% of the stock is currently owned by institutional investors and hedge funds.

cbdMD Company Profile

cbdMD, Inc (NYSEAMERICAN: YCBD) is a Charlotte, North Carolina–based producer and distributor of hemp-derived cannabidiol (CBD) products. Since its founding in 2018, the company has focused on developing a diverse portfolio of wellness offerings designed for human and pet use. Its product range includes tinctures, capsules, gummies, topicals, and pet-specific formulations, each developed to comply with U.S. Food and Drug Administration (FDA) guidelines for hemp-derived substances.

The company operates a vertically integrated business model, sourcing U.S.-grown hemp and overseeing manufacturing processes in cGMP-certified facilities.